Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 — COVID-NET, 10 States, March 2020–February 2022 | MMWR - ISS-G20 Laboratorium Repository

What is already known about this topic?

Immunocompromise is associated with increased risk for intensive care unit (ICU) admission and in-hospital death after SARS-CoV-2 infection. Population-based descriptions of immunocompromised hospitalized patients and their outcomes are limited.

What is added by this report?

Immunocompromised patients accounted for 12.2% of all adult COVID-19 hospitalizations among 10 states and had increased odds of ICU admission and in-hospital death compared with nonimmunocompromised patients, irrespective of vaccination status.

What are the implications for public health practice?

Known multilayered prevention measures, including nonpharmaceutical interventions, up-to-date COVID-19 vaccination, and therapeutics, can prevent hospitalization and subsequent severe COVID-19 outcomes among immunocompromised persons.

Entire content avaialble on: https://www.cdc.gov/mmwr/volumes/71/wr/mm7127a3.htm?s_cid=mm7127a3_w